President Donald Trump has been making false claims about Supreme Court approval for his latest round of tariffs, according to reporting from Politico that revealsPresident Donald Trump has been making false claims about Supreme Court approval for his latest round of tariffs, according to reporting from Politico that reveals

'That is not true': Trump hit with blunt fact check after spreading Supreme Court lie

2026/03/16 02:33
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

President Donald Trump has been making false claims about Supreme Court approval for his latest round of tariffs, according to reporting from Politico that reveals the president is misrepresenting the high court's actual ruling.

Trump has been "repeatedly claiming that the same Supreme Court went ahead and blessed his use of other authorities, like the so-called Section 122 tariffs he's turned to as a short-term fix." However, Politico reports this characterization is inaccurate.

"That is not true," according to the outlet.

While three justices who dissented from the Supreme Court's recent tariff decision did cite Section 122 as a potential tool Trump could use, the court's six-justice majority explicitly rejected that position. Chief Justice John Roberts wrote in the majority opinion: "We do not speculate on hypothetical cases not before us."

The distinction matters significantly for Trump's legal strategy. The president is now relying on Section 122 of the Trade Act of 1974 to justify his 10 percent tariffs imposed in February, claiming the U.S. faces a "large and serious balance-of-payments deficit."

Legal experts acknowledge Trump's new tariffs are on "probably stronger legal footing" than his previous "Liberation Day" taxes that the Supreme Court struck down. However, challengers including Democratic attorneys general from 24 states are already filing lawsuits challenging the legitimacy of Trump's statutory interpretation and the sweeping exemptions his proclamation includes.

Read the full piece here.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Share
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26